Clinical Trial Update: Oral Buprenorphine as a Novel Low-dose Induction Strategy for Opioid Use Disorder [Phase 1]

View source ↗

Summary

This Phase 1 trial update reports completion of a study evaluating a low-dose oral buprenorphine induction strategy for Opioid Use Disorder.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Opioid Use Disorder

Drugs mentioned

• buprenorphine (buprenorphine)

Snippet

Sponsor: Brigham and Women's Hospital | Conditions: Opioid Use Disorder | Phase 1 | Status: COMPLETED